Ravelcare Limited (BOM:544629)
India · Delayed Price · Currency is INR 116.65
-1.25 (-1.06%)
At close: Jul 10, 2026
Ravelcare Revenue
In the fiscal year ending March 31, 2026, Ravelcare had annual revenue of 269.54M INR with 7.91% growth. Ravelcare had revenue of 62.78M in the quarter ending March 31, 2026.
Revenue
269.54M
Revenue Growth
+7.91%
P/S Ratio
2.97
Revenue / Employee
n/a
Employees
20
Market Cap
800.10M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 269.54M | 19.76M | 7.91% |
| Mar 31, 2025 | 249.79M | 28.91M | 13.09% |
| Mar 31, 2024 | 220.88M | 185.94M | 532.23% |
| Mar 31, 2023 | 34.94M | 27.05M | 343.01% |
| Mar 31, 2022 | 7.89M | 7.20M | 1,046.28% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Emami | 37.80B |
| Bajaj Consumer Care | 11.65B |
| Anondita Medicare | 1.37B |
| Recode Studios | 799.50M |
| MFL India | 626.65M |
| Aakaar Medical Technologies | 592.04M |
| Paramount Cosmetics (India) | 213.95M |
| Novateor Research Laboratories | 38.27M |